Aptinyx Inc. (APTX)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 11:58AM EST. Market open.
| Previous close | 0.0620 |
| Open | 0.0620 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 900 |
| Day's range | 0.0620 - 0.0657 |
| 52-week range | 0.0310 - 0.7200 |
| Volume | |
| Avg. volume | 54,532 |
| Market cap | 4.449M |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Horizon (HZNP) Q1 Earnings and Revenues Miss Estimates
Horizon Therapeutics (HZNP) reports lower-than-expected first-quarter 2023 results as it misses the Zacks Consensus Estimates for both revenues and earnings.
- Zacks
Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data
Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine. However, the stock plunges 25% in the absence of efficacy reports.
- Zacks
Agenus (AGEN) Rises on Fast Track Tag for Cancer Combo Drug
The FDA grants Fast Track Designation to Agenus' (AGEN) phase II study evaluating the botensilimab/balstilimab combination in non-MSI-H colorectal cancer patients. The stock jumps 16% following the news.
© 2023 Yahoo. All rights reserved.